Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 38 mg kg-1 | Anti-inflammatory activity in orally dosed Wistar rat assessed as reduction of carrageenan-induced paw edema at 30 mg/kg, po | ChEMBL. | 16730986 |
Inhibition (binding) | = 0 % | Inhibition of microsomal COX1 at 10 uM | ChEMBL. | 16730986 |
Inhibition (binding) | = 0 % | Inhibition of microsomal COX1 at 10 uM | ChEMBL. | 16730986 |
Inhibition (binding) | = 18 % | Inhibition of human recombinant COX2 expressed in sf9 cells infected with baculovirus at 10 uM | ChEMBL. | 16730986 |
Inhibition (binding) | = 18 % | Inhibition of human recombinant COX2 expressed in sf9 cells infected with baculovirus at 10 uM | ChEMBL. | 16730986 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.